The vaccine candidate VPM1002 shows its safety in a study with HIV- and non-HIV-exposed newborns No other infectious disease has killed more people than tuberculosis. Currently, only one vaccine is available to prevent...
An independent data and safety monitoring board (DSMB) overseeing the Phase 3 trial of the investigational COVID-19 vaccine known as mRNA-1273 reviewed trial data and shared its interim analysis with the trial oversight...
It is estimated that there are around 110 vaccine candidates under development of which only eight have so far reached the clinical study phase. According to global brokerage and research firm, Morgan Stanley, of that...
A clinical trial in which volunteers were infected with dengue virus six months after receiving either an experimental dengue vaccine developed by scientists from the National Institutes of Health (NIH) or a placebo...
In clinical trials, several candidate H7N9 pandemic influenza vaccines made from inactivated viruses have been shown to be safe and to generate an immune response. However, scientists believe for practical use, these...
The first human trial of an experimental vaccine against Ebola suggests that it is safe and may help the immune system to combat the virus. Twenty volunteers were immunised in the United States. Scientists at the US...